FEATURED NEWLY DIAGNOSED TRACK PRESENTATION: Forty Years of Autism: Defining the road of hope and healing
Forty years ago I met a magical little boy at the Kaplan Foundation school for children with autism in Orangevale, California. The director, Karen Kaplan, developmental pediatrician Dr. Annette Cartarxo, and I began a journey to discover what was definitively wrong and what would alter the course of this
Patricia C. Kane, PhD
Patricia Kane, PhD, serves as Director of the NeuroLipid Research Foundation, a 501c3 nonprofit organization in Millville,New Jersey. Her expertise in addressing neurological, genetic and epigenetic disorders with targeted bioactive lipid intervention has led to direct neurometabolic application utilized by physicians and researchers worldwide. Dr. Kane's clinical experience, working as a 'living library' for physicians, spans 39 years. She pioneered targeted neurometabolic application of university based red cell fatty acid analysis for the past 21 years. In 2008, she applied a specialized epigenetic analysis ‘a portal into the cell’ whereby images of the membrane surface, phospholipids and mitochondria of each patient along with their DNA adducts were utilized to approach the patient’s epigenetic aberrations. Dr. Kane’s work has expedited the incorporation of current research and evidence based medicine directly into clinical practice to yield resolution of some of the complex medical disorders of our time.Dr. Kane's dedication and success in working with patients with fragile brain architecture has brought her widespread recognition in the field of biometabolic intervention by blending lipid bench science and medical lipid research with clinical medicine.